Cargando…
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene
New therapeutic targets for advanced colorectal cancer (CRC) are critically needed. Our laboratory recently performed an insertional mutagenesis screen in mice to identify novel CRC driver genes and, thus, potential drug targets. Here, we define Transmembrane 9 Superfamily 2 (TM9SF2) as a novel CRC...
Autores principales: | Clark, Christopher R., Maile, Makayla, Blaney, Patrick, Hellweg, Stefano R., Strauss, Anna, Durose, Wilaiwan, Priya, Sambhawa, Habicht, Juri, Burns, Michael B., Blekhman, Ran, Abrahante, Juan E., Starr, Timothy K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193042/ https://www.ncbi.nlm.nih.gov/pubmed/30333512 http://dx.doi.org/10.1038/s41598-018-33527-3 |
Ejemplares similares
-
Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment
por: Burns, Michael B., et al.
Publicado: (2018) -
Population dynamics of the human gut microbiome: change is the only constant
por: Priya, Sambhawa, et al.
Publicado: (2019) -
Transposon mutagenesis in oral streptococcus
por: Zhang, Yixin, et al.
Publicado: (2022) -
LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2
por: Li, Qian, et al.
Publicado: (2019) -
Gut microbiota diversity across ethnicities in the United States
por: Brooks, Andrew W., et al.
Publicado: (2018)